Research programme: skin disorders therapies - Acrux

Drug Profile

Research programme: skin disorders therapies - Acrux

Alternative Names: Research programme: wound healing therapy - Acrux; Skin disorders therapies research programme - Acrux; Wound healing MDTS® topical; Wound healing therapy research programme - Acrux

Latest Information Update: 03 Feb 2011

Price : $50

At a glance

  • Originator Acrux
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Skin disorders

Most Recent Events

  • 22 Aug 2005 This programme is still in active development
  • 13 Jul 2004 Preclinical trials in Skin disorders in Australia (Topical)
  • 13 Jul 2004 This research programme is available for licensing (http://www.acrux.com.au)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top